Yellowfin reporting has signed an agreement in conjunction with Chinese pharmaceuticals company Zuellig Pharma China.
As we welcome in the Chinese New year, and Year of the Pig, Yellowfin looks forward to this auspicious partnership as the Yellowfin founder shares his birthday in the Year of the Pig.
Under the agreement with Yellowfin, Zuellig Pharma China will provide Yellowfin to their clients, which are predominantly hospitals.
Established in 1993, Zuellig Pharma China is a leading distributor of multinational pharmaceuticals in China. With the vision to enter China early, before the Chinese pharmaceutical distribution industry was open to direct foreign investment, Zuellig Pharma China has been able to build a formidable reputation for the highest standards in modern pharmaceutical distribution.
“It is an exciting time as we expand further into more countries abroad, China will give us great opportunities to build our global reputation as well as building a number of new partnerships” said Glen Rabie, CEO of Yellowfin.
This is a significant step for Yellowfin, and the beginning of the company’s entry into the Chinese market. An exciting new development is that together with Zuellig Pharma assistance Yellowfin has been localized for the Chinese market and is available in Simplified Chinese.
“Yellowfin provides us with the functionality, ease of use and a pricing structure that is sensitive to the local market. We are really looking forward to developing this new partnership” Said David Howe, IT Director of Zuellig Pharma.
Zuellig Pharma China plan to provide Yellowfin to their key clients and through this, anticipate an increasing level of sales, customer loyalty and satisfaction.